Topics


Diffuse midline glioma | Treatment | Targeted therapy






Home > Publications > Topics > Diffuse midline glioma > Treatment > Targeted therapy






OVERVIEW












APATINIB






BEVACIZUMAB












DABRAFENIB


DIFFERENTIATION THER

DORDAVIPRONE (ONC201)



DASATINIB












EGFR INHIBITORS

ENZASTAURIN

ERLOTINIB

EVEROLIMUS



NIMOTUZUMAB






OMBURTAMAB






PARP INHIBITORS

PAXALISIB

PI3K/MTOR INHIBITORS




SELUMETINIB






TEMSIROLIMUS

TRAMETINIB

TYROSINE KINASE INH




VEMURAFENIB

VORASIDENIB

VORINOSTAT